Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1982-8-7
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0081-0746
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
193
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-56
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6979370-Administration, Oral,
pubmed-meshheading:6979370-Adult,
pubmed-meshheading:6979370-Aged,
pubmed-meshheading:6979370-Antiviral Agents,
pubmed-meshheading:6979370-Bromodeoxyuridine,
pubmed-meshheading:6979370-Female,
pubmed-meshheading:6979370-Herpes Zoster Ophthalmicus,
pubmed-meshheading:6979370-Humans,
pubmed-meshheading:6979370-Male,
pubmed-meshheading:6979370-Middle Aged
|
pubmed:year |
1981
|
pubmed:articleTitle |
Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus.
|
pubmed:publicationType |
Journal Article
|